Tizenberg, Boris N.
Brenner, Lisa A.
Lowry, Christopher A.
Okusaga, Olaoluwa O.
Benavides, David R.
Hoisington, Andrew J.
Benros, Michael E.
Stiller, John W.
Kessler, Ronald C.
Postolache, Teodor T. http://orcid.org/0000-0001-6056-4244
Article History
Accepted: 6 July 2021
First Online: 1 October 2021
Compliance with Ethical Standards
:
: Dr. Christopher A. Lowry serves on the Scientific Advisory Board of Immodulon Therapeutics, Ltd., is Co-founder and Chief Scientific Officer of Mycobacteria Therapeutics Corporation, serves as an unpaid scientific consultant to Aurum Switzerland AG, and is a member of the faculty of the Integrative Psychiatry Institute. In the past 3 years, Dr. Kessler was a consultant for Datastat, Inc., Holmusk, RallyPoint Networks, Inc., and Sage Therapeutics. Dr. Kessler also has stock options in Mirah, PYM, and Roga Sciences. All other authors did not declare any conflict of interest.
: The authors have approved the final version of the manuscript.
: All reported studies/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional/national research committee standards, and international/national/institutional guidelines).
Free to read: This content has been made available to all.